Concord Biotech Shareholders Approve ₹1 Dividend, Re-appoint Director

About this update from Concord Biotech Ltd.

Concord Biotech held its 40th Annual General Meeting (AGM) on September 9, 2025, where shareholders approved key resolutions, including the declaration of dividend and re-appointment of a director.The shareholders have approved dividend of ₹1 per equity share for the financial year 2024-25.Dividend DetailsParticularsDetailsDividend per share₹1.00Record DateSeptember 2, 2025 Board Meeting HighlightsRe-appointment of Mr. Rajiv Agrawal as Director.Ratification of remuneration of M/s Dalwadi & Associates, Cost Accountants for FY 2025-26 of INR 3,70,000 plus applicable Goods and Service Tax, p.a. and reimbursement of all reasonable out of pocket expenses incurred.Appointment of M/s. Ashish Shah & Associates, Company Secretaries as Secretarial Auditors of the company, for a term of five (5) consecutive financial years commencing from financial year 2025-26 to the financial year 2029-30Approval for Granting Loan, giving Guarantee or providing Security in respect of any loan as per section 185 of the Companies Act, 2013 Voting DetailsThe resolutions were passed with requisite majority, with details of the votes polled as follows:Voting ResultsResolutionVotes in Favour (%)Votes Against (%)Adoption of Audited Standalone and Consolidated Financial Statements99.99900.0010Declaration of Dividend99.99900.0010Re-appointment of Mr. Rajiv Agrawal as Director98.04561.9544Ratification of Remuneration of Cost Auditors99.99890.0011Appointment of Secretarial Auditor99.99890.0011Approval for Granting Loan, giving Guarantee or providing Security in respect of any loan77.118422.8816The meeting was held through video conferencing, with key decisions aimed at strengthening the company's governance and financial oversight. The electronic register, all other papers and relevant records relating to electronic voting shall remain in our safe custody until the Chairman considers, approves and signs the Minutes of the aforesaid Annual General Meeting and the same will be handed over to the Chairman of the Meeting of the Company for safe keeping.

View stock analysis, news, and events for Concord Biotech Ltd.